Investor Relations

Investor
Relations

Investor Communications

NorthStar Healthcare Conference Call - Portfolio Update and 2020 Financial Results

Friday, March 26, 2021 at 4:30 p.m. E.T.

Replay Webcast

 

Supplemental Financial Reports 

Year Ended 2020 Financial Supplement - 3.23.21

Financial Supplemental Update - 1.27.21

Third Quarter 2020 Financial Supplement - 9.30.20

Second Quarter 2020 Financial Supplement - 8.13.20

COVID-19 Update Supplement – 5.27.2020

First Quarter 2020 Financial Supplement – 5.08.2020

Year Ended 2019 Financial Supplement - 3.23.20

Third Quarter 2019 Financial Supplement - 11.14.19

Second Quarter 2019 Financial Supplement - 8.19.19

First Quarter 2019 Financial Supplement - 6.14.19

 

Shareholder Letters

Response to Comrit Tender Offer - 4.14.2021

June 30, 2020 Estimated Per Share Value - 12.21.2020

Response to Comrit Tender Offer - 12.4.2020

Share Repurchase Program Suspension - 4.14.2020

June 30, 2019 Estimated Per Share Value - 12.11.2019

Response to Comrit Tender Offer - 12.11.2019

Monthly Distribution Suspension - 2.7.2019

Amended Share Repurchase Program - 10.15.2018

Response to MacKenzie Tender Offer - 8.13.2018

 

Frequently Asked Questions

On February 7, 2019, NorthStar Healthcare Income, Inc. (the Company) filed a Form 8-K with the Securities and Exchange Commission (SEC) in which the Company announced the suspension of its monthly distribution payments to stockholders. Set forth below are the Company's responses to certain of the more frequently asked questions. For additional information regarding the Company please see the Company’s filings with the SEC.

 FAQ  Download the Frequently Asked Questions PDF